Roman Braun, PhD

Roman Braun, PhD has a diverse work experience that spans various industries, including biotechnology, academia, and security. Roman'smost recent role is Director of Business Development at Envisagenics, where they focus on the discovery of RNA therapeutics. Prior to this, they worked as a Business Development Director at Champions Oncology, Inc. Roman also has experience at SIRION BIOTECH GmbH, where they served as both a Senior Manager and Key Account Manager, consulting on viral vector manufacturing and engineering projects.

In academia, Roman worked as a Postdoctoral Research Fellow at Harvard Medical School, specializing in Hematology/Oncology. Roman conducted laboratory projects analyzing cell death in cancer and viral infection models. Roman was also a Bioinformatics Consultant and Postdoctoral Research Fellow in Immunology at the University of Bern, where they developed innovative vaccine formulations and collaborated with international peers on vaccine development projects.

Outside of the biotech and academic fields, Roman has held positions in the security industry. Roman worked as a Security Supervisor for the World Economic Forum, ensuring security protocols at global events. Roman also served as a Security Officer for Securitas AG, providing security services. Additionally, Roman gained experience in the pharmaceutical industry as a Trainee in Pharmacology and Drug Registration at Bancology S.A.

Furthermore, Roman has showcased leadership and organizational skills as the founding president of IAESTE local committee Bern and a member of the board of IAESTE Switzerland. In this role, they managed a team of volunteers and established collaborations with industry partners and local universities.

Overall, Roman Braun, PhD brings a wealth of experience in business development, biotechnology, academia, security, and leadership to their current role as Director of Business Development at Envisagenics.

Roman Braun, PhD, holds a PhD in Immunology from the University of Bern, which they earned from 2013 to 2016. Prior to their doctoral studies, they completed a Master of Science (M.Sc.) in Molecular Life Science at the University of Bern from 2012 to 2013. Roman'sundergraduate degree is a Bachelor of Science (B.Sc.) in Biological Sciences from the University of Konstanz, which they obtained from 2008 to 2011.

Additionally, Braun has obtained several certifications. Roman completed a Data Science Specialization from Coursera in December 2021. In May 2020, they obtained a certification in Business Development Foundations: Researching Market and Customer Needs from LinkedIn, followed by an Advanced Business Development: Communication and Negotiation certification in April 2020. In January 2020, Braun obtained another Business Development Foundations certification from LinkedIn. In September 2019, they completed the ScientistMBA program from Cheeky Scientist. In July 2019, they obtained a Certificate in Applied Biostatistics from Harvard Catalyst | The Harvard Clinical and Translational Science Center. In August 2018, Braun completed a Specialization in Business Analytics from Wharton Online. Lastly, they obtained FELASA Category B certifications in Laboratory Animal Science for both Mice and Rats in July 2014 and for Ruminants and Pigs in March 2016, both from Universität Zürich.